These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6259398)

  • 41. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
    Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
    Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M; Böswald M; Korn K; Ruder H
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Burkitt's lymphoma].
    Jansen J; van't Veer MB; van Veelen H; Krul EJ; Blok P
    Ned Tijdschr Geneeskd; 1977 Jan; 121(4):133-9. PubMed ID: 189235
    [No Abstract]   [Full Text] [Related]  

  • 46. Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma.
    Hirshaut Y; Cohen MH; Stevens DA
    Lancet; 1973 Jul; 2(7821):114-6. PubMed ID: 4124041
    [No Abstract]   [Full Text] [Related]  

  • 47. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Etiological factors in Burkitt's disease].
    Capdevielle P; Darie H; Barabé P
    Med Trop (Mars); 1983; 43(3):227-33. PubMed ID: 6310311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong.
    Lo S; Ho WK; Wei WI
    Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to Epstein-Barr virus associated antigens in Burkitt's lymphoma.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P; Singh S
    Bibl Haematol; 1973; 39():813-7. PubMed ID: 4360196
    [No Abstract]   [Full Text] [Related]  

  • 52. Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma.
    Mukojima T; Gunvén P; Klein G
    J Natl Cancer Inst; 1973 Oct; 51(4):1319-21. PubMed ID: 4355608
    [No Abstract]   [Full Text] [Related]  

  • 53. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EVB-associated immune complexes and recurrent Burkitt's lymphoma.
    Gunven P; Klein G; Rosen A; Mukojima T
    IARC Sci Publ (1971); 1978; (24 Pt 2):875-82. PubMed ID: 221409
    [No Abstract]   [Full Text] [Related]  

  • 58. [Maxillofacial location of Burkitt's lymphoma in children treated at the University Hospital Center in Bamako, Mali: a 24-case series].
    Togo B; Keita M; Medefo D; Traore F; Sidibe T
    Med Trop (Mars); 2008 Dec; 68(6):600-2. PubMed ID: 19639827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoantibodies in three populations of Burkitt's lymphoma patients.
    Vainio E; Lenoir GM; Franklin RM
    Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stability and dissociation of P3H4-1 Burkitt's lymphoma cell soluble complement-fixing antigen identified with human serum.
    Weliky N; Leaman DH; Kallman BJ
    Cancer Res; 1975 Jun; 35(6):1580-5. PubMed ID: 236823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.